Xiangqun Li

Xiangqun Li is the Co-Founder & CEO at Zonsen Peplib Biotech. Xiangqun has over 20 years of experience in the biotechnology industry.

Li started their career as a Researcher at the Biomolecular Engineering Research Institute in Osaka, Japan. Xiangqun then became a STA Fellow at the Osaka National Research Institute. In 1997, they became a COE Researcher at Osaka University.

Xiangqun then moved to the United States to pursue their PhD at Purdue University. After completing their PhD, they became a Postdoc Fellow at the University of Maryland. In 2007, they returned to China to become the Director of Peptide Department at GenScript Coporation.

In 2013, Li became the VP at Kaijie Peptide Company. In 2016, they co-founded Zonsen Peplib Biotech and has been serving as the CEO ever since.

Some individuals on their team include Huanzhang Gong - Co-Founder & SVP, Liu Wenge - Executive Director, Pharmacology Department, and Cheng Lei - Co-Founder & President.